My question is this: Lympro is a diagnostic test to distinguish those with
Alzheimers from those with other forms of dementia, correct? Then how do
you enroll people in this study who are in the early to late stage of
Alzheimers. How do you know whether they have Alzheimers first before
the test is even administered, in order to enroll them as representing the
cohort of people with ALzheimers????
Alzheimers from those with other forms of dementia, correct? Then how do
you enroll people in this study who are in the early to late stage of
Alzheimers. How do you know whether they have Alzheimers first before
the test is even administered, in order to enroll them as representing the
cohort of people with ALzheimers????